Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis-Reference-Cited by-同舟云学术

Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis

Published:2018-12 Issue:6 Volume:50 Page:648-654
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:

Author:

Geven Christopher,Peters Esther,Schroedter Mathias,Struck Joachim,Bergmann Andreas,McCook Oscar,Radermacher Peter,Kox Matthijs,Pickkers Peter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference41 articles.

1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3);Singer;JAMA,2016

2. Sepsis in European intensive care units: results of the SOAP study;Vincent;Crit Care Med,2006

3. Epidemiology of severe sepsis: 2008-2012;Stoller;J Crit Care,2016

4. Benchmarking the incidence and mortality of severe sepsis in the United States;Gaieski;Crit Care Med,2013

5. Sepsis: pathophysiology and clinical management;Gotts;BMJ,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Modern Landscape of Sepsis: Advances in Diagnosis and Treatment;International Journal of Molecular Sciences;2024-07-05

2. A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections;Cells;2024-05-22

3. Vascular leak in sepsis: physiological basis and potential therapeutic advances;Critical Care;2024-03-23

4. Global trends in research on endothelial cells and sepsis between 2002 and 2022: A systematic bibliometric analysis;Heliyon;2024-01

5. Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass;Clinical Chemistry and Laboratory Medicine (CCLM);2023-10-24